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The inhibition of Newcastle disease, influenza A and B, and mumps viruses 
by a  labile component present in normal serum has been described previously 
(1). In addition to complement another component of normal serum, distinct 
from complement, was required for viral inhibition.  Inactivation of virus by 
this  inhibitor  was  temperature-dependent, appeared  to  require calcium,  and 
under usual circumstances the virus did not dissociate spontaneously from the 
inhibitor. These findings were in agreement with those of other investigators 
(2--4) and characterized the heat-labile inhibitor of normal serum as a mecha- 
nism distinct from antibody (1--4) or heat-stable (Francis) inhibitors of viral 
hemagglutination (2--4). 
The requirements and kinetics of the interaction of the properdin system 
with zymosan (5, 6) and certain erythrocytes (5,  7, 8) bore a  resemblance to 
the requirements and kinetics of the inhibition of virus by the heat-labile com- 
ponent of serum  (1). Therefore, preliminary experiments were carried out to 
determine whether the properdin system had any viral inhibiting properties. 
Such inhibiting properties were found (9). Since that time, it has been shown 
that the properdin system has a variety of activities including the lysis of cer- 
tain erythrocytes (7, 8) and the destruction of various bacteria (10) and pro- 
tozoa (11). 
The purpose of this paper is to describe in detail the experiments which indi- 
cate that the properdin system can inactivate Newcastle disease virus (NDV); 
that such viral inactivation equates with the other described activities of the 
properdin system; and that the inhibition of hemagglutination by Newcastle 
disease virus (NDV) is partially reversible. 
* This investigation  was supported in part by grants from the United States Public Health 
Service (H-1643 (C)); the Office  of the Surgeon General, Department of the Army, under the 
sponsorship of the Commission on Acute Respiratory Diseases, Armed Forces Epidemiologic 
Board; and from the Lederle Laboratories Division, American Cyanamid Company. 
This work was presented in part to the Society for Pediatric Research, June 15, 1955. 
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Nomenclature 
The nomenclature used throughout is similar to that of all previous papers in this series 
(5,  7,  10,  12,  13).  The abbreviations in the text, figures,  and  tables  are designated in the 
section on materials and methods. The term RP is used in a generic sense  to describe serum 
rendered deficient in properdin alone. 
Materials  and  Methods 
Diluents.-- 
Barbit~  Buffev.--Barbital  buffer was prepared  as previously described  (12,  14).  When 
noted, magnesium and calcium were added in concentrations of 1.5 X  10  --4 M and 4.2 X  10  -4 
K respectively. 
Citrate Buffer.--2.5  per cent sodium citrate was used. 
Phosphate Buffer.--Isotonic  saline buffered at pH 7.2 with 0.01 g phosphate was employed. 
Tryptose Phosphate Brotk.--Difco  bacto-tryptose  phosphate  broth,  containing penicillin 
(50 units per ml.)  and  streptomycin  (0.5  rag.  per ml.)  was used  as  the diluent in all in- 
fectivity studies. 
Zymosan.-- 
This insoluble polysaccharide complex of yeast cell walls was prepared as previously de- 
scribed (12,  15). The zymosan employed in this study met criteria previously established for 
the preparation of reagents (12). 
Human Serum Reagents.-- 
Fresk Human Serum.--Blood  was drawn from healthy donors and  the serum separated 
and  stored as previously described  (10).  Occasional sera were encountered  that  contained 
heat-stable inhibitor; this inhibitor resisted heating at 56°C. for 30 minutes and when tested 
was sensitive to culture filtrate of Vibrio cholera (RDE)  prepared  as previously described 
(16).  Five to 10 per cent of fresh sera tested had agglutinin titres of 1:8 or higher against 
chick red cells. Heat-stable inhibitor of viral hemagglutination and chick red cell agglutinins 
interfered with the studies  of the serum heat-labile inhibition presented in this paper and 
therefore, sera containing either of these factors were discarded. 
Properdin.--I-Iigl~y purified  human  properdiu  dissolved in barbital  buffer  (5,  12),  was 
used throughout.  The properdin concentration of the purified material and of test reagents 
was determined by the zymosan assay (12). 
Serum  Deficient in Properdin  (RP).--The  preparation  of serum  deficient in  properdin 
(RP)  for a  reagent has been described previously (5,  12),  and it has been pointed out that 
not all sera  can  be satisfactorily depleted of properdin  alone by a  single adsorption  with 
zymosan (5,  6,  10,  12,  13). A double adsorption with zymosan was found necessary to de- 
plete serum of properdin  satisfactorily for bactericidal studies  (10).  For these experiments 
RP was prepared either in a  manner identical with that for bactericidal studies  (10)  or by 
triple adsorption with zymosan. For a  variety of reasons presented and discussed  elsewhere 
(10, 12) only 10 to 20 per cent of serum samples yielded satisfactory RP. 
Serum Deficient in Components of Complement.--Reagents lacking individual complement 
component activity were prepared  from fresh human serum and characterized by standard 
methods (12,  14):  R1, the reagent lacking Cq, and R2, the reagent lacking C~2, by dialysis 
against acetate buffer (pI-I 5.6, ionic strength 0.02); R3,  the reagent lacking C'3, by incuba- 
tion with zymosan  at  37°C.; R4, serum  lacking C'4, by incubation with hydrazine. In one 
experiment  partially purified  C~3, prepared  from human  plasma  fraction III (Cohn),  was 
kindly supplied  by  Dr.  Florence Roth  (17). R.  J.  WEDGW0OD~  H.  S.  GINSBERG~  AND  L.  PILLEM~R  ~09 
Heated serum, inactivated at 56°C. for 30 minutes, lacking C'l, C'2, C'3, and properdin, 
was used as a general control for all experiments. 
Resin-Treated Serum.--Serum  was  rendered  deficient of  magnesium  and  calcium  with 
cation exchange resin, amberllte IRC-50 in the sodium cycle, by methods previously described 
(10,  18).  Such resin treatment of serum has been found to reduce the concentration of mag- 
nesium and calcium to less than 1 X  10  -6 tt without inactivating complement or properdin. 
Newcastle disease virus (Hickman strain) was chosen as the test agent because antibody 
to it, which would have interfered with the test procedures, is rarely found in human serum. 
Newcastle disease virus (NDV) was propagated in the aliantoic sac of 10 day embryonated 
chick eggs. Eggs were inoculated with 0.2 ml. of a  10  "e dilution of NDV infected allantoic 
fluid and incubated at 35°C.  for 40 hours. Following chilling, the eggs were harvested for 
ailantoic fluid.  Generally the allantoic fluid containing the NDV was dialyzed  against 80 
volumes of barbital buffer for 12 to 24 hours in the  cold (4°C.) before  use. Such pools had 
hemagglutinatiou titres of 1: 256 to 1 : 1024 and infectivity titres of 109 a EIDs0 per ml. 
For  certain experiments dialyzed  virus was  rendered deficient in  magnesium  and  cal- 
cium  by  resin  treatment  in  the  same  manner  as  the  resin  treatment  of  serum. 
In one experiment influenza A and B  viruses (PR8 and Lee strains), cultivated in chick 
embryos in a  manner similar to  that described  for  NDV,  were  used. 
Chicken Red  Cdls.-- 
Chicken red ceils stored in Alsever's solution, or as a  "stabilized 5 per cent suspension" 
(Cappel Laboratories, West Chester, Pennsylvania) were suspended to a  0.5 per cent con- 
centration in barbital, citrate, or phosphate buffer on the day of use. 
Storage.-- 
All serum, reagents, properdin, and virus were quick frozen and stored at  -70°C.  until 
the day of use. During test procedures, unless otherwise mentioned, all reagents and mixtures 
were  kept  chilled  at  4°C. 
All glassware used was chemically cleaned in sulfuric acid-dichromate solution and 
thoroughly  with  distilled  water. 
Determination of Viral Inhibition and Activity.- 
It has been shown previously (1, 2) that the complex of virus and heat-iabile inhibitor is 
stable, and that the virus does not dissociate freely from the inhibitor, as is the case with 
Francis' inhibitors (2, 19, 20). Chick cell agglutinins and other factors in human serum may 
under the conditions of "constant serum, varying dilutions of virus" and the converse "con- 
stant virus, varying dilutions of serum" titrations interfere with,  and often obliterate the 
end point of hemagglutination. All titrations to determine the degree of viral inhibition were 
carried out as follows: Equal volumes of test serum or serum reagent and virus were mixed 
together and incubated at 37°C. for 30 minutes. The residual quantity of active virus was 
then titrated by preparing dilutions of the virus-serum mixture, and testing these for hemag- 
ghitinating or infectious activity. 
Hemagglulinatlon Titration.- 
Double dilutions of serum-vlrus mixture in 0.4 ml. of buffer were made. To each dilution 
and to an aliquot of the undiluted serum-virus mixture an equal volume (0.4 ml.) of 0.5 per 710  PROPERDIN  SYSTEM AND  IMMUNITY.  VI 
cent chicken red cells was added. The reagents were mixed by shaking, and after incubation 
at 4°C. for 60 minutes the tubes were read for hemagglutination patterns.  The highest dilu- 
tion showing definite hemagglutination was recorded as the end point. The hemagglutination 
titre is the reciprocal of this dilution. The inhibitory activity of the serum or reagent is re- 
ported as an "inhibition index." The inhibition index is the ratio between the hemagglutination 
(control titre) ~. 
titre of the control (buffer or heated serum) and  the test reagent; i.e.,  ~  .-:----:  3race 
(reagent titre). 
unity is the least index obtainable by this computation (when the control and test reagent 
tltres are identical), it should be remembered throughout that an inhibition index of one by 
hemagglutination indicates no inhibition. 
Infe~li~ty  Titra~ms.-- 
Ten-fold dilutions of the serum-virus mixture were made in tryptose-phosphate  broth. 
0.2 mL of each dilution was inoculated into the allantoic sac of 10 day emhryonated chicken 
eggs.  Four eggs were used for each dilution. Following 40 hours' incubation,  the eggs were 
chilled and the allantoic fluid harvested. The presence of virus in the allantoic fluid was de- 
termined by hemagglutination titrations and the EID6o calculated (21).  Inhibitory activity 
is reported as an "inhibition index," defined as the ratio between the EIDs0 of the control 
(control  titre) 
and the test reagent: (reagent titre)" In infectivity titrations this is expressed  as the logarithm 
of the inhibition index calculated by subtracting the log of the titre in the reagent from the 
log of the titre in the control; i.e.,  log EID~0 in control minus log EIDs0 in reagent. 
EXPEI~  ~  NTAL 
The Properdin Requirement  for Viral Inhibition by Human Serum 
The initial  experiment was  designed  to determine whether properdin was 
an essential component for the inhibition of viral activity by serum. 
Equal volumes of NDV and serum, heated serum (56°C. for 30 minutes), RP, RP to which 
properdin was added  (5 units per ml.), properdin alone in barbital buffer with added mag- 
nesium and calcium (5 units per ml.), or barbital buffer with magnesium and calcium alone 
(control)  were mixed and  incubated  at  37°C.  for 30 minutes.  Following incubation,  viral 
activity was determined  by hemagglutlnation titrations.  A  similar experiment using infec- 
tivity titrations  to determine viral activity was also performed. 
The findings (Table I) indicate that properdin was necessary for the inhi- 
bition of virus by the heat-labile factors of normal serum. Fresh serum inhibited 
virus as determined by both hemagglutination and infectivity titrations. The 
inhibitor was heat-labile, since heated serum gave little or no inhibition. When 
serum was rendered properdin deficient (RP) there was a distinct reduction in 
viral inhibition.  The readdition  of properdin  to  RP  restored  the  inhibitory 
activity. Properdin alone, however, was never inhibitory. 
In all experiments in which infectivity was used as an index of viral activity, 
a reduction in viral inhibition could be demonstrated following the removal of 
properdin from serum in the preparation of RP. Experiments in which hemag- 
glutination was employed as an index of viral activity were not as uniformly 
satisfactory. In almost every instance in which the parent serum and RP were R.  J.  WEDGWOOD, H.  S.  GINSBERG, AND L,  PILLEMER  711 
tested  simultaneously,  there  was  considerably  less  viral  inhibition  by  RP. 
Many sera adsorbed two times with zymosan, however, still inhibited hemag- 
glutination by NOV to a  significant degree. Readdition of properdin to those 
adsorbed sera having the highest inhibition indices did not result in an increase 
of viral inhibition--probably because of the large amount of properdin not ad- 
sorbed by zymosan (vide infra).  Another group of zymosan-adsorbed sera had 
no viral inhibitory activity and failed to inhibit hemagglutination by NDV 
after properdin was added--complement had probably been reduced in these 
sera  (10). The remaining adsorbed sera fulfilled all criteria for a  satisfactory 
RP: They had markedly reduced viral inhibitory activity and on addition of 
TABLE I 
The Requirement  for Properdin in t~ Inhibition of Viru~ 
Test reagent 
Serum 
Heated serum 
RP 
RP with added properdin 
Properdin alone 
Barbital buffer 
Test procedure 
Hemagglutination  Infectivity 
Inhibition  Titre  index* 
4  64 
256  1 
32  8 
4  64 
256  1 
256  1 
Log inhibition  Log EID~  index~ 
5.3  4.2 
9.5  0.0 
8.5  1.0 
5.0  4.5 
9.5  0.0 
9.5  0.0 
control titre 
* Inhibition index ffi 
reagent titre 
Log inhibition index -- log EID~0 control -- log EIDs0 test reagent, 
properdin the viral inhibitory activity was  restored to levels comparable to 
that of the original serum. 
It was concluded from these experiments that properdin was necessary for 
the action of the heat-labile viral inhibitor in normal serum. Properdin, how- 
ever, was not effective alone; additional factors present in serum were needed. 
It was also apparent that maximal removal of properdin in the preparation of 
RP affected these other factors in serum (probably complement) necessary for 
the system. Less complete removal of properdin, while sparing these factors, 
did not necessarily produce a  decrease in inhibitory activity, because of the 
residual  properdin.  Therefore, in  the preparation  of an RP  satisfactory for 
studies of viral inhibition, a compromise was necessary; an RP was required in 
which properdin was removed maximally but which still retained satisfactory 
serum cofactor levels. Such requirements are not unique, and have also been 
found in the study of the other activities of the properdin system (10). 712  PROPERDIN  SYSTEM  AND  IMMUNITY.  VI 
The Relationship between Properdin Concentration  and Viral Inh~Con 
Previous experiments suggested that properdin was necessary for the inhibi- 
tion  of virus,  but  the amount  of properdin  required  for complete inhibition 
was small. Therefore, experiments were carried out to determine the quantita- 
tive  relationship  between  properdin  concentration  and  the  degree  of  viral 
inhibition. 
Constant volumes of increasing dilutions of properdin were added to allquots of an RP 
to give final concentrations of properdin ranging from 0.008 to 8 units per ml. of RP. The 
capacity of each reagent and appropriate controls to inhibit NDV was measured by the hemag- 
glutination technique. 
The Relationshlp between Pro 
Test reagent 
;erum 
RP 
[-Ieated RP (56°C.) 
RP +  properdin 
TABLE II 
,erdin Concentration and Viral In~ 
Properdln 
concentration  HemsgU~tlnatioa 
4 
32 
256 
4 
8 
8 
4 
4 
32 
4-6 
8 
2 
0.5 
0.125 
0.031 
O. 008 
Inhibition 
index* 
64 
8 
1 
64 
32 
32 
64 
64 
8 
* Inhibition index =ffi 
control titre 
reagent titre 
The initial experiment utilized hemagglutination as an index of viral activity 
(Table II). The parent serum had an inhibition index of 64 units. RP alone had 
some inhibitory activity. Heated RP had no antiviral effect. The addition of 
0.008 units of properdin per ml. of RP did not increase the inhibition above 
that found in the RP alone. The addition of 0.03 units of properdin per ml. of 
RP, however, restored the inhibitory activity to the level seen in the original 
serum. The addition of increasing amounts of properdin did not further enhance 
the degree of inhibition. The demonstration that as little as 0.5 per cent of the 
original serum concentration of properdin induced maximal inhibition empha- 
sizes the fact previously noted that almost complete removal of properdin in 
the preparation of RP was required to abolish viral inhibitory activity by serum. 
The assay of inhibition by hemagglutination titrations under the conditions 
used was sensitive only between levels of 50 and 98 per cent inhibition.  The 
use of infectivity titrations to determine viral inhibition was sensitive with the R. ]. WEDGWOOD~  H. S. GINSBERG~  AND  L. PILLEMER  713 
method employed when over 90 per cent of the virus was inactivated. Similar 
experiments using infectivity titrations were therefore carried out to determine 
whether the degree of viral inhibition could be quantitatively related to proper- 
din concentration when larger quantities of properdin were employed. 
Properdin was added to aliquots of an RP in concentrations ranging from 0.1 unit to 20.0 
units per ml. The parent serum, heated serum, RP, aliquots of RP to which varying concen- 
trations of properdin were added, properdin alone (5 units per ml. in barbital buffer with added 
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Fro. 1.  The  relationship  between  properdin  concentration  and  the  quantity  of  virus 
inhibited. 
magnesium and  calcium), heated  RP,  and barbital buffer alone (with magnesium and  cal- 
cium) were incubated with an equal volume of NDV and the quantity of virus inhibited de- 
termined by infectivity titrations. 
The results presented (Fig.  1)  summarize the geometric means of data ob- 
tained from two comparable experiments. In these experiments heated serum, 
heated RP, and properdin alone were non-inhibitory. The parent sera had a 
log inhibition index of 3.8; the RP was significantly less inhibitory, having a 
log inhibition index of 1.6. The addition of as little as 0.1 unit of properdin per 
ml. of RP gave a distinct increase in the quantity of virus inhibited. There was 
a  progressive increase in viral inhibition as properdin was added until a  con- 
centration of 2.5 units per ml. was reached. The inhibition index at this proper- 714  PROPERDIN  SYSTEM AND  "r~r~,.rU~ITY. VI 
din concentration was similar to that of the parent serum. Increasing amounts 
of properdin above this concentration did not increase viral inhibition. Indeed, 
the data suggest that excessive  amounts of properdin may interfere with the 
antiviral effect. 
The increase in viral inhibition with increments of properdin up to 2.5 units 
per mi., while quantitative, was not a  first order reaction. By extrapolation  1 
the residual activity of the RP (log inhibition index of 1.6) would be equivalent 
to approximately 0.01  unit per ml. of properdin.  Since the parent sera  con- 
tained between 4 and 8 units per ml., it can be estimated that the preparation 
of RP removed more than 99.8 per cent of the properdin present in the fresh 
serum. The inability of properdin in excess of 2.5 units per ml. to increase viral 
inhibition suggests that factors other  than properdin  in  the  serum may be 
limiting. 
These findings are similar to those reported for the quantitative aspects of 
the  bactericidal  activity of  the  properdin  system  (10);  in  the  bactericidal 
studies also, excessive properdin concentrations interfered with the activity of 
the system. 
The Requirement  for the Components of Complement in Viral Inhibition 
In all the previous experiments it was apparent that serum factors in addition 
to properdin were also necessary for, and could limit, viral inhibition. Experi- 
ments were, therefore, carried out to determine the requirement for the com- 
ponents of complement in viral inhibition by normal serum. 
Serum reagents deficient in single components of complement were prepared. R1, R2, R3, 
and R4 were each added to aliquots of NDV and the quantity of virus inhibited in each mix- 
ture ascertained by hemagglutination and by infectivity titrations.  Similarly, the inhibitory 
activity of the parent  sera,  and  of the reagents with added properdin was determined.  In 
one experiment properdin and partially purified C'3 (17) were added to R3 in a similar type 
of procedure. 
All four components of complement were needed for viral inhibition (Table 
III) R1, the reagent lacking C'I, R2, the reagent deficient in C'2, and R4, the 
reagent in which C'4 had been inactivated, without, or even with properdin 
added, had essentially no inhibitory activity. R3, the serum rendered deficient 
in C'3, alone retained some inhibition in the infectivity test. The addition of 
properdin to R3 did not significantly increase viral inhibition. The addition of 
C'3 to the R3 with added properdin, however, resulted in the inactivation of 
significantly greater amounts of NDV. The R3 was not totally deficient in C'3; 
approximately 10 per cent of the C'3 was left in the reagent during preparation. 
It is probable that the residual inhibition in this reagent was, therefore, due to 
I log  inhibition  index  =  3.6  +  log  (properdin  concentration);  for  concentrations  of 
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the traces of C'3 and properdin that had not been removed. The recombination 
of R1 and R2, restored all components to the system, and likewise restored the 
ant§viral effect. 
It can be concluded from these experiments that for viral inhibition, as for 
the lysis of bacteria or erythrocytes (7, 8,  10), all four components of comple- 
ment are required in addition to properdin.  The effect of the system  can be 
TABLE III 
The Requirements  for Complement in the Intdbltlon of Virus 
Test reagent 
Parent serum 
R1 
R1 +  properdin 
R2 
R2 +  properdin 
R3 
R3 +  properdin 
R3 +  C'3 +  properdin 
R4 
R4 +  properdin 
R1 +  R2 
Component  known to be absent 
P  C'I  C'2 
+  + 
+ 
+ 
+ 
+ 
C'3 
+§ 
+§ 
C'4 
+ 
+ 
Inhibition  index 
From hemag-  From 
glut§nation*  infectivity 
log snits$ 
16  3.0 
1  0.0 
I  0.1 
1  0.5 
1  0.5 
1  1.2 
1  1.4 
Not done  2.5 
1  0.1 
1  0.1 
8  Not done 
control titre 
* Inhibition index =  reagent titre' control titre =  128. 
:~ Log inhibition index =  log EID~0 in control -- log EIDs0 in test reagent. Log EID60 
in control =  approximately 9.0. 
§ This preparation of R3 was not entirely free of C'3; between  30 and 40 units (10 per 
cent of the original concentration) of C'3 per ml. were present in the reagent at the concentra- 
tion used. 
limited by a  deficiency in any one of these four components, and when suscep- 
tible to experimentation the readdition of the missing component can be shown 
to restore inhibitory activity. 
The Cation Requirement for Viral Inhibition 
For  all  reported  activities magnesium  is  an  absolute  requirement  for  the 
properdin system. A  series of experiments were performed, therefore, to see if 
this was the case for the inhibition of Newcastle disease virus. 
To 0.4 ml. aliquots of resin-treated serum was added 0.04 ml. of a solution containing either 
M/10 barium, calcium, cobalt, copper, iron, magnesium, manganese, or potassium. The cation 
solutions were made from the most soluble chloride salt available. To each was added 0.4 ml. 
of dialyzed and resin-treated NDV. Controls containing resin-treated serum and cation alone, 716  PROPERDIN  SYSTEM  AND  I~NITY.  VI 
and NDV with cation alone were tested in parallel. Similar experiments were performed using 
resin-treated RP, and resin-treated RP with added properdin. 
Resin treatment of serum completely removed the heat-labile viral inhibitory 
activity. This  activity could be restored by the readdition of magnesium  or 
TABLE IV 
The Cation Requirement for the Inhibition  of Virus 
Barium 
Calcium 
Cobalt 
Copper 
Iron 
Magnesium 
Manganese 
Potassium 
Cation added to reagent  Inhibition index* 
1 
1 
1 
1 
2? 
32 
32 
1 
Resin-treated serum alone (no added cation) ...........  1 
control titre 
* Inhibition index --  Inhibition index of serum before resin treatment ~  32. 
reagent titre" 
Hemagglutination titre of dialyzed and resin-treated NDV: (control)  ffi 128. 
TABLE V 
The Cation Requirement for the Inhibition  of Virus by Propodin in RP 
Fresh serum 
RP (serum lacking properdin) 
RP with added properdin 
c~  ~c  ~c  ~c 
Cation added 
Calcium  Magnesium 
+  + 
0  0 
+  + 
0  0 
+  O 
0  + 
+  + 
Inhibition 
index* 
16 
1 
1 
1 
1 
16 
16 
* Inhibition index ffi 
control titre 
reagent titre' control titre ~  128. 
manganese  (Table IV).  Barium,  calcium,  cobalt,  copper,  and potassium had 
no  effect;  the  inhibitory activity did  not  return  on  the  readdition of  these 
cations. Since the addition of ferrous salts resulted in the formation of a  pre- 
cipitate in the serum-virus mixture following incubation, the inhibition index 
of serum with added iron is in doubt. No significant increase in inhibitor titre 
was  found  with  added iron.  The  cations in  the  concentrations  used  did not R.  J.  WEDGWOOD,  H.  S.  GINSBERO~  AND  L.  PILLEMER  717 
inhibit NDV by themselves, nor did they alone cause sufficient agglutination 
of the chicken red cells to interfere with the experiments. 
In order to show specifically the requirement for magnesium in the properdin 
system, additional studies were made using resin-treated RP with and without 
added properdin (Table V). These data add further evidence that magnesium 
but not calcium was an essential component of the properdin system in the 
inhibition of virus. Furthermore, the results indicate clearly that calcium did 
not enhance the inhibition attained with magnesium alone. 
TABLE VI 
The Cation Re4uirement for the Inhibition  of NDV, Lee, and PR 8 Virus in Guinea Pig Serum 
Virus added to 
resin-treated serum 
NDV 
LEE 
PR8 
Calcium 
0 
+ 
0 
÷ 
0 
+ 
0 
÷ 
0 
+ 
0 
+ 
Magnesium 
0 
0 
+ 
÷ 
0 
0 
+ 
+ 
0 
0 
÷ 
÷ 
Cation added 
Inhibition ivdex* 
1 
1 
16 
16 
1 
1 
16 
16 
control titre  * Inhibition Index 
reagent titre" Control titre: NDV -- 512; Lee -- 128; PR8 ffi 1024. 
The data of Ginsberg and Horsfall (1)  suggested that calcium rather than 
magnesium was required for viral inhibition. Much of their data were obtained 
using guinea pig serum with Newcastle disease or influenza viruses. Therefore, 
further experiments were carried out using resin-treated guinea pig serum and 
dialyzed,  resin-treated  NDV,  and  influenza  A  and  B  virus  (PR8  and  Lee 
strains). 
Procedures identical with the above were carried out using resin-treated guinea pig serum 
and dialyzed, resin-treated NDV, Lee, and PR8 viruses. In these experiments magnesium 
and  calcium only were added. In all experiments  viral activity and inhibition were deter- 
mined by hemagglutination titrations. 
It was apparent again from these experiments (Table VI) that magnesium, 
not  calcium, was required  for viral  inhibition.  Calcium  neither  restored in- 718  PROPERDIN  SYSTEM  AND  IMMUNITY.  VI 
hibitory activity nor enhanced the inhibition induced by magnesium. Such re- 
sults were obtained consistently; in every sample tested magnesium but not 
calcium restored inhibitory activity to resin-treated serum.  There  is thus a 
discrepancy between this and previous reports (1, 2). 
The data of Ginsberg and Horsfall (1) were obtained by depleting serum of 
calcium and magnesium using dialysis and the addition of citrate. The depletion 
of calcium in this manner may render complement unstable (18, 22). However, 
the removal of magnesium (and calcium) would not be complete. It is entirely 
possible that sufficient magnesium was present in their system to allow inhi- 
bition upon the readdition of enough calcium to protect and maintain the com- 
plement content of the serum. The addition of magnesium would not afford 
such  protection,  and  thus  complement might  have  been  inactivated  when 
magnesium alone was added. Since the properdin system requires complement, 
in addition to properdin, :the inactivation of complement in a calcium-deficient 
system could explain their results. The ion exchange resin used in the present 
studies removes cations more rapidly and efficiently, thereby diminishing the 
danger of inactivation of complement. 
The data presented here indicate that magnesium is a  requirement for the 
inhibition of virus by the properdin system. In this requirement the inhibition 
of virus is  entirely similar to  all other reported activities of the properdin 
system. Of the other cations tested, manganese alone could replace magnesium 
in the system. The concentration of manganese required precludes the possi- 
bility that this metal has any significance in the inhibition of virus when such 
inhibition occurs naturally in serum. 
The Thermal Dependence of Viral Inhibition 
In contrast to the interaction of antigen and antibody, the optimal interac- 
tion of the properdin-zymosan complex with CP3 requires temperatures of incu- 
bation above  15°C.  (5).  The  characteristics  of the  thermal requirement for 
viral inhibition were therefore determined by the following experiments. 
Tubes containing  0.4 ml. of virus and 0.4 mi. of serum were incubated for 30 minutes at 
temperatures ranging from  0°C. to 45°C. Twofold  dilutions were then made in cold 2.5 per 
cent citrate buffer using chilled pipettes. Chicken  red cells in cold citrate buffer were added. 
As a control,  parallel tubes containing  heated serum and virus, and barbital buffer  and virus 
were treated similarly.  Viral activity was determined  by hemagghitination  titrations. 
In a series of such experiments (Fig. 2) inhibition of virus never occurred at 
temperatures below 10°C. Between 10°C. and 20°C. no inhibition or occasional 
slight inhibition could be  demonstrated. At  temperatures above  20°C.  viral 
inhibition invariably occurred,  maximal inhibition appearing  uniformly be- 
tween 30°C. and 40°C. Temperatures above 45°C. inactivated the virus, making 
determinations at higher temperatures impossible. R.  J.  WEDGWOOD~ H.  S.  GINSBERG,  AND  L.  PILLEMER  719 
These data indicate that the thermal requirement for viral inhibition is simi- 
lar to that of the other manifestations of the properdin system (5,  I0). 
The Effect of the Inhibition of Virus on the Components 
of the Properdin  System 
While components of complement are needed for the interaction of properdin 
with substances such as zymosan and certain polysaccharides, the interaction 
does not  necessarily inactivate  the  component required  (13).  In  the  classic 
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inactivation of complement by zymosan, CI3 alone of the four components is 
destroyed (5, 15). At 15°C. to 17°C. the interaction of properdin with zymosan 
does not even inactivate CI3  (5),  and  certain preparations of zymosan and 
some polysaccharides, while combining avidly with properdin, do not inactivate 
C~3 at higher temperatures (up to 37°C.) (12,  13). The data of previous inves- 
tigators indicated that the inactivation of virus by the heat-labile inhibitor in 
normal serum removed inhibitor without affecting complement (1, 2). 
In order to ascertain the effect of the inhibition  of virus  on the  properdin 
system, properdin, complement, and complement component titres were deter- 
mined  on  serum  following  incubation  with  virus  and  were  compared  with 
similar determinations on serum incubated with allantoic fluid. 
Equal volumes of dialyzed NDV or normal allantoic fluid and serum were mixed. Follow- 
•ng  incubation (37°C. for 30 minutes), the inactivation of the virus was determined  by hemag- 720  PROPERDIN  SYSTEM AND  ]'M'MUNITY. VI 
glutination fitrations and the properdin titres d  the serum incubated with NI)V and d  the 
serum incubated with normal allantoic fluid were determined by zymosan assay (12) and bac- 
tericidal activity (10). Similarly  complement and complement  component titres were meas- 
ured. Controls  using heated serum and barbital buffer were used in parallel. 
The results of such experiments are  summarized in  Table VII.  Following 
incubation of serum and virus, there was significantly less properdin available 
in the serum mixed with virus than in the serum to which allantoic fluid had 
been added. The sera incubated with allantoic fluid contained an average of 8 
units of properdin per ml.; the sera incubated with virus, 5 units of properdin 
per ml. The total hemolytic complement and  complement  component  titres 
in both groups of sera  were slightly less  than usually found in fresh serum, 
particularly with regard to C'I and C'2. This decrease was probably related 
to the well known instability of complement, especially C'I and C'2, when di- 
luted serum is incubated, and was believed to represent the slight spontaneous 
TABLE  VII 
The Effect of the Inhibition of Virus on Properdin and Complement  in Serum 
Titre of components  of the properdin  system 
Test mixture  after incubstion,  unils per ~d serum 
P  C'  C'I  C'2  C'3  C'4 
Serum +  NDV  5  76  280  200  280  960 
Serum +  no alaHantoic uid  I  8  I  72  I  360  I  1601  2801 
Hemagglutination titre of NDV =ffi 1024; inhibition index of serum =  32. 
deterioration of complement that would be expected following the incubation 
of  any  diluted  serum.  The  complement  (C')  and  complement  component 
(C'I, C'2, C'3, and C'4) titres of the sera mixed with NDV or normal allantoic 
fluid, however, were not significantly different. 
It can be concluded that the inhibition of virus, which requires properdin, 
rendered a  significant mount  of properdin unavailable. On  the other hand, 
while all components of complement are also required, the inhibition of virus 
did not affect them,  or else  affected them to  such a  slight degree that the 
changes were not detectable by the techniques employed. 
The Restoration of ttemagglutinating Activity to Previously Inactive 
Virus-Serum Mixtures by Prolonged Incubation with Cation 
Exchange Resin 
The  similarity between  the  requirements  for  the  interaction of virus  or 
zymosan with  the properdin  system and  the  demonstration that,  following 
inhibition  of  virus,  available  properdin  concentrations  are  decreased,  sug- 
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interaction  of properdin  with  zymosan or polysaccharide.  Properdin  can  be 
dissociated from zymosan (5).  Previous experiments (1)  suggested that when 
serum-virus mixtures containing inactivated virus were exposed to citrate for 
prolonged periods of time, there resulted a restoration of some hemagglutinating 
activity. Experiments were therefore designed to determine whether the  expo- 
sure of serum-virus mixtures to cation exchange resin would result in the release 
or restoration of viral activity. 
Equal volumes of fresh or heated serum and NDV were incubated at 37°C. for 30 minutes 
and  the hemagglutinstion titre of the residual virus in the mixture determined. To  each 
serum-virus mixture an equal volume of cation exchange  resin, amberlite IRC-50 in the sodium 
cycle, was added and aliquots of the mixtures reincubated, at 37°C. for 30 to 90 minutes; 
TABLE  VIII 
E.~ect of Incubation with Cation Exchange Resin on Inhibition of NDV by Fresh Serum 
Reaction mixture* 
Fresh serumandNDV 
Heated serum and N-DV 
37°C. 
m/n. 
90 
90 
90 
90 
22°C. 
k~,$. 
18 
18 
Incubstlon with resin  Hemsg~lutination 
titre 
64 
64 
256 
1024 
512 
512 
* Previously incubated at 37°C. for 30 minutes. 
at 4°C. for 18 hours; or at room temperature (22°C.) for 18 hours after incubation at 37°C, for 
90 minutes. Suitable controls without resin were treated in a .qlmilax manner. During incuba- 
tion, the resin was intermittently  remixed with the serum-virus mixture by gentle inversion. 
Following the entire procedure, the degree of viral activity was again measured. All deter- 
minations of viral activity were made by hemagglutination titrstions. 
The result of one such experiment is summarized in Table VIII. Incubation 
of serum-virus mixtures with cation exchange resin for short periods of time 
(at 37°C. for 30 to 90 minutes) or for long periods of time in the cold (18 hours 
at 4°C.) did not influence the hemagglutination titre of the mixture. Incubation 
of serum-virus mixtures with resin at room temperature for 18 hours following 
incubation at 37°C. did, however, result in a  significant restoration of hemag- 
glutinating activity. Incubation of suitable controls, with or without resin, in a 
similar manner had no affect on the hemagglutination titre of such mixtures. 
In a  series of six such  experiments,  comparable and  significant  release  of 
virus was obtained under these conditions. At no time, however, was complete 
reappearance of hemagglutinating  activity induced.  Generally only 10  to 50 722  PROPERDIN  SYSTEM  AND  IMMUNITY.  VI 
per cent of viral hemagglutinating activity could be restored to the m~xture in 
this manner. The limited reappearance of viral  (hemagglutinating) activity 
has precluded satisfactory infectivity experiments. These data and the data 
previously obtained (1) do, however, indicate that inhibition of viral activity, 
as evidenced by hemagglutination at least, was reversible  to a certain extent 
under these conditions. 
DISCUSSION 
It is apparent from the experiments described here that the properdin system 
can inactivate Newcastle disease  virus.  Inhibition of virus requires all  the 
known constituents of the properdin system: properdin, all four components 
of complement and magnesium. The removal of any one of these results in a 
loss of inhibition; replacement of the missing  constituent restores antiviral 
effect. These findings identify the properdin system as a single system capable 
of viral inhibition,  lysis of certain erythrocytes (7, 8) and bacteria (10) and 
destruction of protozoa (11). 
The differences between the properdin system and systems requiring anti- 
body, which are apparent from the distinctly separable factors involved, have 
been previously discussed  (5,  10). The differentiation of inhibitors for virus 
has also been reviewed by many authors (1-4).  The studies presented here, 
which equate the properdin system with the heat-labile inhibition of virus how- 
ever, permit further differentiation.  The Francis type of inhibitor is recognized 
by heat stability, susceptibility to destruction by RDE, and eventual dissocia- 
tion of virus from the inhibitor (2, 19, 20). This substance is a mucoprotein and 
inhibits hemagglutination, not infectivity, of the myxoviruses (2, 20). In con- 
trast, antibody and heat labile inhibitor,  which do affect infectivity, are clas- 
sically distinguished  from each other by the thermal instability of the latter 
(1-4). Furthermore, inhibition of virus by the properdin system, as shown here, 
requires complement but does not inactivate it; in contrast, inactivation of 
virus by antibody does not require complement, although when complement is 
present it may be "fixed" by the antigen-antibody combination.  It is of interest 
that  "fixation" of complement by antigen-antibody interaction induces the 
inactivation of C'I, C'2, and C'4; C'3 is not affected (22). Ct3, which is inac- 
tivated by the interaction of properdin and zymosan at 37°C., has previously 
been shown to be necessary only for the lysis of specifically sensitized erythro- 
cytes and bacteria in systems requiring antibody (23). 
The properdin system contains six known variables, all of which are essential 
for the viral inhibitory effect of serum. Five of the variables, properdin and the 
four components of complement, are relatively unstable. They may lose activity 
on handling, storage, or heating, and may be inactivated by seemingly innocent 
procedures; for example, through activation of the plasmin system (18, 22). 
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occur, and it is  not surprising,  therefore,  that differences  exist  in the literature 
concerning the role of complement for the inactivation of virus  by the heat- 
labile  inhibitor  (I-4,  24).  Some of these differences  may bc related  to the pro- 
tection or inactivation of complement  by the technical  procedures used; for 
instance, the destruction of complement  by trypsin (1, 25). The removal of 
inhibitor  by adsorption with V. ChoI~a extracts,  which has been shown to be 
independent of RDE  activity (2),  may be similarly  related  to the interaction 
of properdin with endotoxin, polysaccharide or cell  walls (13). 
Viral  inhibition  results  in a decrease in the amount of available  properdin in 
serum without affecting  the concentration of the components of complement 
in  a measurable fashion.  Thus it  seems likely  that virus  and propcrdin interact, 
possibly  in  a stoichiometric  manner similar  to the interaction  of  properdin with 
zymosan  or polysaccharide. The components  of complement  would then be 
considered as cofactors.  The relationship  between properdin concentration and 
viral inhibition  is not inconsistent  with this  hypothesis of stoichiometric  pro- 
portions.  In addition,  it  has been demonstrated that there  exists  a quantitative 
relationship between  magnesium  concentration and viral inhibition by the 
properdin system (26),  similar  to that of the bactericidal  activity (10).  This 
interaction  also  suggests a stoichiometric  relationship.  When serum-virus mix- 
tures containing inactivated virus were incubated for prolonged pcriods with 
citrate (I) or a cation exchange resin,  dissociation  of virus with hemagglutin- 
ating activity  occurred. Since  both these  procedures decrease or remove avail- 
able magnesium  from  the system,  these findings become  of interest. The 
dependence on magnesium  for the initial  interaction of virus and propcrdin, 
and the finding that conditions which remove available  magnesium  result  in 
restoration of hemagglutinating  activity,  suggest that magnesium may be an 
integral part of the virus-properdin complex. That hemagglutinating  activity 
never returns completely suggests  that either  the bond, it  it  exists,  is  extremely 
firm,  or that  further  interaction  with magnesium is  prevented by a process  such 
as stcric  hindrance. It is  further  possible  that a certain  proportion of the virus 
which reacted with the properdin system is irreversibly  inactivated. 
Heat-labile inhibitors  of virus have long been recognized (I-4, 27, 28) and 
have on occasion  been considered a "laboratory" nuisance" (4).  The description 
of the properdin systcm as a single  system with bactericidal  as well  as antiviral 
activities  warrants speculation  on the viruses  that may be affected.  The proper- 
din system appears identical  with the inhibitors  described for  mumps, influenza 
A and B viruses,  as well  as Newcastle disease  virus  (I-4),  and has requirements 
similar to those of the factor which neutralizes vaccinia and variola viruses 
(27,  29).  In addition to these  animal viruses,  we have recently  been able  to con- 
firm the observations (30) that the properdin system inhibits  at least  one bac- 
terial  virus (E. Coli  phage T2). Apart from these  viruses  which are inactivated 
in the absence of  antibody, the occurrence of  a heat-labile  factor  in  serum which 724  PROPERDIN  SYSTEM AND  IMMUNITY.  VI 
potentiates the neutralization of Western equine encephalomyelitis,  Rous sar- 
coma, dengue,  and herpes simplex viruses (24, 31-35) has been described. This 
factor may also be the properdin system. The requirement for antibody does 
not preclude  the  participation  of the properdin  system; antibody,  and  the 
properdin system may act synergistically as has been found in the destruction 
of Toxoplasma gondii (11, 36). 
There is no available evidence to indicate whether the properdin system has 
antiviral activity in vlvo. Even though such viral inhibition may exist, the inhi- 
bition of virus would not be a general phenomenon.  Many groups of viruses are 
notably resistant to inactivation by the properdin system; for example,  fresh 
serum is conspicuously non-inhibitory for the poliovirnses  (37).  Inhibition of 
virus may also resemble the lysis of bacteria in that susceptibility to the proper 
din system may be a property of the strain, not of the species (2, 10). Finally, 
although from a  teleologic viewpoint it is unlikely that the properdin system 
exists in serum without function, the fact that mumps virus is readily inacti- 
vated in vitro by the heat-labile inhibitor of human serum (1), and yet viremia 
is an important aspect of the pathogenesis of mumps, presents an unresolved 
dichotomy. 
SUMMARY 
Detailed experiments are presented which indicate that the properdin system 
is an inhibitor of Newcastle disease virus. Viral  inhibition required all known 
components of the properdin system: properdin, all four components of com- 
plement and magnesium; the removal of any one constituent resulted in a loss 
of inhibition; the replacement of the constituent restored antiviral effect. The 
inhibition  of virus was temperature-dependent.  The process of inhibition  by 
serum resulted in a decrease in the amount of properdin available in the serum 
without any measurable effect on the components of complement. The pro- 
longed incubation of inactive serum-virus mixtures with cation-exchange resin 
resulted in the restoration of some, but not all, of the hemagglutinating activity 
of the virus. The requirements of the properdin system and the implication of 
these findings were discussed. 
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